checkAd

     229  0 Kommentare Kapruvia (difelikefalin) recommended by England’s NICE for the treatment of adults with moderate-to-severe CKD-associated pruritus - Seite 3

    CSL Vifor Media Contact

    Thomas Hutter
    M. +41 79 957 96 73
    E. media@viforpharma.com

    Cara Therapeutics Contacts:

    Media Contact
    Annie Spinetta
    6 Degrees
    M. +1 973-768-2170 
    E. aspinetta@6degreespr.com

    Investor Contact
    Iris Francesconi, PhD
    Cara Therapeutics
    M. +1 203-406-3700
    E. investor@caratherapeutics.com

    References:

    1. Rayner, H. C., Larkina, M., Wang, M., Graham-Brown, M., van der Veer, S. N., Ecder, T., … Pisoni, R. L. (2017). International Comparisons of Prevalence, Awareness, and Treatment of Pruritus in People on Hemodialysis. Clinical journal of the American Society of Nephrology, 12(12), 2000–2007. doi:10.2215/CJN.03280317
    2. Nidhi Sukul, Angelo Karaboyas, Philipp A. Csomor, Thilo Schaufler, Warren Wen, Frédérique Menzaghi, Hugh C. Rayner, Takeshi Hasegawa, Issa Al Salmi, Saeed M.G. Al-Ghamdi, Fitsum Guebre-Egziabher, Pablo-Antonio Urena-Torres, and Ronald L. Pisoni. Self-reported Pruritus and Clinical, Dialysis-Related, and Patient-Reported Outcomes in Hemodialysis Patients. Kidney Medicine 3(1):42-53. Published online 2020.
    3. Mathur VS, et al. A longitudinal study of Uremic Pruritus in hemodialysis patients. Clin J Am Soc Nephrol. 2010; 5(8):1410-1419

    Seite 3 von 3



    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    Kapruvia (difelikefalin) recommended by England’s NICE for the treatment of adults with moderate-to-severe CKD-associated pruritus - Seite 3 Recommendation will enable eligible patients in England, Wales and Northern Ireland to access the first licensed treatment for moderate-to-severe chronic kidney disease (CKD)-associated pruritus in adult patients on haemodialysisST. GALLEN, …